Nuvation Bio Inc. - Common Stock (NUVB)

Historical Holders from Q1 2021 to Q3 2025

Symbol
NUVB on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
339,200,672
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
220,552,252
Holdings value
$817,854,049
% of all portfolios
0%
Number of holders
201
Number of buys
119
Number of sells
65
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Nuvation Bio Inc. - Common Stock (NUVB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +11% $83,994,714 +$8,820,664 50,599,225 +12% FMR LLC 31 Mar 2025
BlackRock, Inc. 6.4% +30% $47,542,366 +$11,538,315 21,708,843 +32% BlackRock, Inc. 30 Jun 2025
As of 30 Sep 2025 Nuvation Bio Inc. - Common Stock (NUVB) has 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 220,552,252 shares of 339,200,672 outstanding shares and own 65% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Nuvation Bio Inc. - Common Stock (NUVB) own 57% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
FMR LLC 15% $187,110,754 50,570,474 -0.92%
Decheng Capital LLC 7.7% $96,031,424 25,954,439 0%
BlackRock, Inc. 7.3% $91,035,389 24,604,159 -4.4%
VANGUARD GROUP INC 4.6% $57,182,001 15,454,595 -2.8%
Laurion Capital Management LP 2.9% $35,910,468 9,705,532 -5.2%
Omega Fund Management, LLC 2.6% $32,675,029 8,831,089 -20%
STATE STREET CORP 1.8% $22,529,985 6,089,185 +9.5%
GEODE CAPITAL MANAGEMENT, LLC 1.7% $21,788,082 5,887,755 -1.8%
MILLENNIUM MANAGEMENT LLC 1.4% $17,953,207 4,852,218 -9.8%
Nuveen, LLC 1.3% $16,896,794 4,566,701 +207%
TANG CAPITAL MANAGEMENT LLC 1.2% $15,540,000 4,200,000 +7.7%
ABRAMS CAPITAL MANAGEMENT, L.P. 1.1% $14,102,598 3,811,513 0%
DIMENSIONAL FUND ADVISORS LP 0.98% $12,275,869 3,321,249 +20%
Redmile Group, LLC 0.89% $11,214,733 3,031,009 0%
Aisling Capital Management LP 0.87% $10,954,438 2,960,659 +17%
Octagon Capital Advisors LP 0.78% $9,743,336 2,633,334 -66%
TWO SIGMA INVESTMENTS, LP 0.7% $8,797,009 2,377,570 +96%
JANE STREET GROUP, LLC 0.68% $8,592,262 2,322,233
CITADEL ADVISORS LLC 0.68% $8,526,476 2,304,453 -58%
ARMISTICE CAPITAL, LLC 0.68% $8,495,200 2,296,000 +359%
NORTHERN TRUST CORP 0.62% $7,835,386 2,117,672 +1.6%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.61% $7,605,332 2,055,495 -3.5%
AQR CAPITAL MANAGEMENT LLC 0.6% $7,526,581 2,034,211 +79%
Pale Fire Capital SE 0.43% $5,345,194 1,444,647 +1410%
MORGAN STANLEY 0.39% $4,882,133 1,319,495 +9.1%

Institutional Holders of Nuvation Bio Inc. - Common Stock (NUVB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 220,552,252 $817,854,049 -$1,522,989 $3.70 201
2025 Q2 224,729,650 $439,155,420 +$34,613,506 $1.95 179
2025 Q1 207,335,118 $364,911,558 +$18,852,489 $1.76 159
2024 Q4 197,748,566 $526,027,143 +$38,581,662 $2.66 159
2024 Q3 187,137,100 $428,593,745 +$73,088,420 $2.29 153
2024 Q2 152,508,500 $445,373,270 +$51,019,388 $2.92 145
2024 Q1 134,652,746 $490,114,274 +$4,259,118 $3.64 122
2023 Q4 64,304 $97,099 $1.51 1
2023 Q3 136,892,011 $183,439,502 -$9,239,470 $1.34 122
2023 Q2 139,011,387 $250,194,706 +$3,219,592 $1.80 120
2023 Q1 137,479,282 $228,215,121 -$4,710,028 $1.66 126
2022 Q4 139,524,431 $267,880,499 -$12,049,127 $1.92 121
2022 Q3 140,557,944 $314,850,714 -$43,877,603 $2.24 111
2022 Q2 155,087,543 $502,310,398 -$21,839,858 $3.24 114
2022 Q1 159,066,695 $836,700,347 +$14,054,167 $5.26 111
2021 Q4 122,352,875 $1,039,654,594 +$18,872,709 $8.50 99
2021 Q3 151,142,281 $1,502,010,648 +$33,771,301 $9.94 95
2021 Q2 147,981,911 $1,364,633,796 +$16,304,202 $9.31 97
2021 Q1 145,559,447 $1,478,100,000 +$1,473,702,226 $10.45 72